- Home
- DCTH vs CARE Comparison
DCTH vs CARE Comparison
Compare DCTH & CARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCTH
- CARE
- Stock Information
- Founded
- DCTH 1988
- CARE 1974
- Country
- DCTH United States
- CARE United States
- Employees
- DCTH N/A
- CARE N/A
- Industry
- DCTH Medical/Dental Instruments
- CARE Major Banks
- Sector
- DCTH Health Care
- CARE Finance
- Exchange
- DCTH Nasdaq
- CARE Nasdaq
- Market Cap
- DCTH 388.3M
- CARE 456.8M
- IPO Year
- DCTH N/A
- CARE N/A
- Fundamental
- Price
- DCTH $11.10
- CARE $19.38
- Analyst Decision
- DCTH Strong Buy
- CARE Buy
- Analyst Count
- DCTH 4
- CARE 1
- Target Price
- DCTH $24.50
- CARE $22.00
- AVG Volume (30 Days)
- DCTH 681.8K
- CARE 81.0K
- Earning Date
- DCTH 11-07-2025
- CARE 10-23-2025
- Dividend Yield
- DCTH N/A
- CARE N/A
- EPS Growth
- DCTH N/A
- CARE 154.06
- EPS
- DCTH 0.06
- CARE 1.36
- Revenue
- DCTH $70,240,000.00
- CARE $153,120,000.00
- Revenue This Year
- DCTH $159.22
- CARE $10.85
- Revenue Next Year
- DCTH $42.78
- CARE $14.12
- P/E Ratio
- DCTH $197.68
- CARE $14.27
- Revenue Growth
- DCTH 491.35
- CARE 21.78
- 52 Week Low
- DCTH $8.08
- CARE $13.61
- 52 Week High
- DCTH $18.23
- CARE $20.53
- Technical
- Relative Strength Index (RSI)
- DCTH 45.00
- CARE 54.87
- Support Level
- DCTH $10.43
- CARE $18.95
- Resistance Level
- DCTH $11.28
- CARE $19.69
- Average True Range (ATR)
- DCTH 0.41
- CARE 0.39
- MACD
- DCTH -0.02
- CARE -0.08
- Stochastic Oscillator
- DCTH 23.22
- CARE 52.50
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
About CARE Carter Bankshares Inc.
Carter Bankshares Inc is a bank holding company that conducts its business solely through the bank. The Bank earns revenue from interest on loans and securities and fees charged for financial services provided to customers. It offers a full range of deposit services including Lifetime Free Checking, interest checking accounts, savings accounts, retirement accounts and other deposit accounts of various types, ranging from money market accounts to longer-term CDs. The Bank offers a full range of commercial and consumer loans. The Bank also originates and holds fixed and variable-rate mortgage loans and offers home equity lines of credit to its customers.